A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

NCT02608359 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No subjects recruited in the study

Conditions

Prostate Cancer

Interventions

DRUG: Abiraterone Acetate

Sponsor

Johnson & Johnson Private Limited